Breaking News

Grand River Opens Second Manufacturing Facility

August 26, 2014

Will house finishing ops, inspection services, storage and larger lab

Grand River Aseptic Manufacturing (GRAM) has opened an additional facility for high-quality parenteral contract manufacturing in Grand Rapids, MI. The new 28,000-sq.-ft. facility will house the company's finishing operations, inspection services, storage and a substantially larger lab.
A ribbon-cutting ceremony for the new facility will be held at 9:30 a.m. on Thursday, August 28th. Grand Rapids' Mayor George Heartwell will attend, along with GRAM president Tom Ross, investors, suppliers, building contractors and employees.
Mr. Ross said, “We are very excited to celebrate our expansion in Grand Rapids. GRAM began operations in December 2010 at our facility on 140 Front Avenue in Grand Rapids and we have outgrown that 11,400 square foot facility. Our cleanroom, lab and offices will remain at 140 Front Avenue and represents a significant amount of capital investment. As our company has signed new customers and hired many new employees, we were looking for the right space to handle future growth. Importantly, we now have room to grow and can add new cleanrooms in our new facility.”
Mr. Ross added, “In 2013, GRAM had 25 employees and today we have over 50 highly trained and educated technical staff dedicated to exceptional pharmaceutical services. We appreciate the support of our investors, employees and the West Michigan community as we expand our role in the life sciences effort in our state. The ribbon cutting is an opportunity for GRAM to celebrate with all stakeholders of the company.”
blog comments powered by Disqus
  • API Sourcing Trends

    Kristin Brooks, Contract Pharma||April 11, 2016
    Drug product complexities, quality and regulatory hurdles drive market shift

  • U.S. Pharma Market Trends

    Kristin Brooks, Contract Pharma||April 8, 2016
    CPhI Report sees return of generic and API manufacturing to U.S. market

  • Flexible Manufacturing Strategies

    Kristin Brooks, Contract Pharma||April 4, 2016
    Michael Lehmann of Patheon discusses solutions for pharmaceutical forecasting errors

  • CMO Systems

    CMO Systems

    Philip K. Burns, CRO Consulting||April 5, 2016
    A CMO system includes four aspects of the product lifecycle: regulatory, technical, compliance, and operations.

  • Injectables: The New Oral?

    Injectables: The New Oral?

    Tugrul Kararli, Kurt Sedo, Josef Bossart, PharmaCircle LLC||April 5, 2016
    The growth trend of injectables continues across the pharma landscape.

  • Biopharmaceutical Contract Manufacturing Contract Negotiations

    Biopharmaceutical Contract Manufacturing Contract Negotiations

    William Downey, HighTech Business Decisions||April 5, 2016
    Navigating the complexities of supply agreements.